The global forensic swab industry is experiencing significant growth due to the increasing demand for advanced forensic equipment for clinical and criminal investigations, as well as the need to address security issues. The worldwide forensic swab market is expected to grow from USD 4.98 billion in 2025 to USD 7.40 billion by 2032, according to market reports that reflect a robust compounded annual growth rate (CAGR).
Many notable companies, including Puritan Medical Products, COPAN Diagnostics Inc., SARSTEDT AG & Co. and MWE, are leading this growth as they present new evidence collection swab products designed to support both microbial testing and the recovery of DNA and trace evidence, as well as being effective in human presence detection. They are focused on providing high precision, contamination control swab products and developer-user-friendly evidence collection products that allow forensic lab professionals and law enforcement to achieve better accuracy and faster results.
A significant factor contributing to growth is the increase in crime rates, cyber-enabled fraud and public health emergencies, which necessitate valid biological sample collection. Moreover, the increased adoption of probabilistic DNA tools and digital chain of custody systems has made it impossible to envision a modern justice system that does not rely on forensic swab samples.
Considerations suggest that North America and Europe are market leaders due to increasingly sophisticated forensic infrastructures, while the Asia-Pacific is presenting as a fast-growing region due to increased government investments in forensic science.
This indicates not only growing an industry but, importantly, a step towards strengthening global justice and public safety.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.